journal article·2022-03Open access

Mineralized Peyronie's plaque has a phenotypic resemblance to bone

Putu Ustriyana, Matthew R. Hennefarth, Sudarshan Srirangapatanam, Haeyoon Jung, Yongmei Wang, Ling Chen, Tom F. Lue, Guiting Lin, Misun Kang, Marshall L. Stoller, Sunita P. Ho

Acta Biomaterialia· Volume 140

Abstract

Mineralized Peyronie's plaque (MPP) impairs penile function. The association, colocalization, and dynamic interplay between organic and inorganic constituents can provide insights into biomineralization of Peyronie's plaque. Human MPPs (n = 11) were surgically excised, and the organic and inorganic constituents were spatially mapped using multiple high-resolution imaging techniques. Multiscale image analyses resulted in spatial colocalization of elements within a highly porous material with heterogenous composition, lamellae, and osteocytic lacuna-like features with a morphological resemblance to bone. The lower (520 ± 179 mg/cc) and higher (1024 ± 155 mg/cc) mineral density regions were associated with higher (11%) and lower (7%) porosities in MPP. Energy dispersive X-ray and micro-X-ray fluorescent spectroscopic maps in the higher mineral density regions of MPP revealed higher counts of calcium (Ca) and phosphorus (P), and a Ca/P ratio of 1.48 ± 0.06 similar to bone. More importantly, higher counts of zinc (Zn) were localized at the interface between softer (more organic to inorganic ratio) and harder (less organic to inorganic ratio) tissue regions of MPP and adjacent softer matrix, indicating the involvement of Zn-related proteins and/or pathways in the formation of MPP. In particular, dentin matrix protein-1 (DMP-1) was colocalized in a matrix rich in proteoglycans and collagen that contained osteocytic lacuna-like features. This combined materials science and biochemical with correlative microspectroscopic approach provided insights into the plausible cellular and biochemical pathways that incite mineralization of an existing fibrous Peyronie's plaque. STATEMENT OF SIGNIFICANCE: Aberrant human penile mineralization is known as mineralized Peyronie's plaque (MPP) and often results in a loss of form and function. This study focuses on investigating the spatial association of matrix proteins and elemental composition of MPP by colocalizing calcium, phosphorus, and trace metal zinc with dentin matrix protein 1 (DMP-1), acidic proteoglycans, and fibrillar collagen along with the cellular components using high resolution correlative microspectroscopy techniques. Spatial maps provided insights into cellular and biochemical pathways that incite mineralization of fibrous Peyronie's plaque in humans.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Urological Disorders and Treatments · Sexual function and dysfunction studies · Vitamin D Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (45)

Show source-provided references
1. Peyronie's disease: a critical appraisal of current diagnosis and treatment10.1038/ijir.2008.30 ↗
2. The management of Peyronie's disease: evidence-based 2010 guidelines10.1111/j.1743-6109.2010.01850.x ↗
3. Peyronie's disease10.1093/ajcp/45.6.670 ↗
4. Regulation of vascular calcification in atherosclerosis
5. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells10.1016/S0891-5849(01)00610-4 ↗
6. Risk factors for emotional and relationship problems in Peyronie's disease10.1111/j.1743-6109.2008.00949.x ↗
7. Heterotopic Ossification: a Comprehensive Review10.1002/jbm4.10172 ↗
8. Peyronie's Disease: a Review
9. All about Peyronie's disease10.1016/j.ajur.2015.04.019 ↗
10. Simulation of early calcific aortic valve disease in a 3D platform: a role for myofibroblast differentiation10.1016/j.yjmcc.2016.03.004 ↗
11. Vascular smooth muscle cell differentiation to an osteogenic phenotype involves matrix metalloproteinase-2 modulation by homocysteine10.1007/s11010-015-2432-0 ↗
12. Phosphate regulation of vascular smooth muscle cell calcification10.1161/01.RES.87.7.e10 ↗
13. Gene Expression during Vascular Pericyte Differentiation10.1615/CritRevEukaryotGeneExpr.v9.i1.10 ↗
14. Progenitor cells of the testosterone-producing Leydig cells revealed10.1083/jcb.200409107 ↗
15. Peyronie's Disease: an Electron Microscopic Study10.1016/S0022-5347(17)54513-9 ↗
16. Mechanisms of Calcification in Peyronie's Disease10.1016/S0022-5347(17)53599-5 ↗
17. Ultrastructural Changes in Impotent Penile Tissue: a Comparison of 65 Patients10.1016/S0022-5347(17)38443-4 ↗
18. Mineral density volume gradients in normal and diseased human tissues10.1371/journal.pone.0121611 ↗
19. The watershed transform: definitions, algorithms and parallelization strategies10.3233/FI-2000-411207 ↗
20. Fiji: an open-source platform for biological-image analysis10.1038/nmeth.2019 ↗
21. Biomineralization of Dental Tissues Treated with Silver Diamine Fluoride10.1177/00220345211026838 ↗
22. Compact bone mineral density of the normal human radius10.3109/02841867809127938 ↗
23. Limited Trabecular Bone Density Heterogeneity in the Human Skeleton
24. Tunica-sparing ossified Peyronie's plaque excision10.1111/j.1464-410X.2010.09546.x ↗
25. Penile ossification: a traumatic event or evolutionary throwback? Case report and review of the literature10.5489/cuaj.249 ↗
26. Bone saw for calcified Peyronie's disease plaques10.1016/j.urology.2015.04.027 ↗
27. Shape factors of bones and teeth affect mineral density maps
28. Histology—A Text and Atlas10.1136/jcp.29.1.82-a ↗
29. Calcium orthophosphates: crystallization and dissolution10.1021/cr0782574 ↗
30. Sodium, Potassium, Phosphorus, and Magnesium10.1007/978-1-4939-2001-3_24 ↗
31. Distribution of magnesium, calcium, sodium and potassium in tissues of the hip joint10.1684/mrh.2013.0348 ↗
32. Biomineralization and matrix vesicles in biology and pathology10.1007/s00281-010-0230-z ↗
33. Organization of apatite crystals in human woven bone10.1016/S8756-3282(02)00945-6 ↗
34. The pathophysiology of heterotopic ossification: current treatment considerations in dentistry10.1016/j.jdsr.2013.07.003 ↗
35. Matrix metalloproteinases (MMPs) in oral diseases10.1111/j.1601-0825.2004.01038.x ↗
36. Matrix metalloproteinases in wound repair (review)10.3892/ijmm.6.4.391 ↗
37. Evidence that osteogenic progenitor cells in the human tunica albuginea may originate from stem cells: implications for peyronie disease10.1095/biolreprod.105.041038 ↗
38. Proteolytic host cell enzymes in gingival crevice fluid10.1034/j.1600-0757.2003.03106.x ↗
39. Matrix Metalloproteinases in Bone Resorption, Remodeling, and Repair10.1016/bs.pmbts.2017.05.001 ↗
40. Extracellular matrix alterations in the Peyronie's disease10.1016/j.jare.2017.06.004 ↗
41. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture10.1016/j.urology.2004.04.006 ↗
42. Expression of matrix metalloproteinase-2 and -9 during early human wound healing
43. Differential effects between the loss of MMP-2 and MMP-9 on structural and tissue-level properties of bone10.1002/jbmr.326 ↗
44. Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-kappaB signaling10.1007/s10787-017-0309-4 ↗
45. Alkaline Phosphatase and Hypophosphatasia10.1007/s00223-015-0079-1 ↗